Elise Mitri
banner
elisemitri.bsky.social
Elise Mitri
@elisemitri.bsky.social
Drug Allergy Pharmacist, Austin Health
PhD candidate, Doherty Institute, University of Melbourne
Reposted by Elise Mitri
Is one dose ever enough? The PROSPECTOR 🪓 Trial will answer - A international double blind placebo controlled trial of 1 dose vs 5 day for #penicillinallergy. This week we recruited our 100th patient! 🎉 @thedohertyinst.bsky.social
November 21, 2025 at 11:04 AM
Reposted by Elise Mitri
The largest adult #penicillinallergy study ever undertaken - The iNAAN study @thedohertyinst.bsky.social @unimelb.bsky.social - 52 hospitals, 8 countries and over 5000 patients….Real world proof of the safety and effectiveness of inpatient DOC! Stay tuned #AMS folks 👀Results soon!
November 21, 2025 at 11:50 PM
Reposted by Elise Mitri
🆕🔥State-of-the-Art Review with 🌟s @trubianojason.bsky.social : Antibiotic Allergy—A Multidisciplinary Approach to Delabeling #idsky
url: academic.oup.com/cid/article/...
November 6, 2025 at 8:09 PM
Reposted by Elise Mitri
The SULF-FAST tool, used to assess sulfonamide allergy risk, successfully identified patients with low risk for safe oral challenges, resulting in a 95% rate of negative reactions. https://ja.ma/45ZxzLq
July 7, 2025 at 10:25 PM
Reposted by Elise Mitri
Penicillin allergy delabelling is an effective form of antimicrobial stewardship. And can be pharmacist-led.
👏 @elisemitri.bsky.social @trubianojason.bsky.social
#IDSky #AMR #ClinMicro @cmicomms.bsky.social
December 20, 2024 at 4:01 PM